Evidence map›Paper›PMID 27830400›Full record

ArticleCancer causes & control : CCC2016

Serum B

Joyce Y Huang, Lesley M Butler, Øivind Midttun, Woon-Puay Koh, Per M Ueland, Renwei Wang, Aizhen Jin, Yu-Tang Gao, Jian-Min Yuan

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Joyce Y HuangDivision of Cancer Control and Population Science, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue - Suite 4C, Pittsburgh, PA, 15232, USA.
Lesley M ButlerDivision of Cancer Control and Population Science, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue - Suite 4C, Pittsburgh, PA, 15232, USA. butlerl3@upmc.edu.
Øivind MidttunBevital A/S, Bergen, Norway.
Woon-Puay KohDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Per M UelandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Renwei WangDivision of Cancer Control and Population Science, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue - Suite 4C, Pittsburgh, PA, 15232, USA.
Aizhen JinNational Registry of Diseases Office, Health Promotion Board, Singapore, Singapore.
Yu-Tang GaoShanghai Jiaotong University, Shanghai, China.
Jian-Min YuanDivision of Cancer Control and Population Science, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue - Suite 4C, Pittsburgh, PA, 15232, USA.
University of Pittsburgh · USUPMC Hillman Cancer Center · USBevital (Norway) · NOHealth Promotion Board · SGNational University Health System · SGShanghai Jiao Tong University · CNUniversity of Bergen · NO

Funding

Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
NCI NIH HHS R01 CA144034NCI NIH HHS UM1 CA182876
6 · The paper itself

Abstract

backgroundVitamin B

methodsTo determine whether levels of serum B

resultsThe median (5th-95th percentiles) concentrations of serum PLP among control subjects of the Shanghai and Singapore cohorts were 25.7 (10.0-91.7) nmol/L and 58.1 (20.8-563.0) nmol/L, respectively. In pooled analyses, high serum PLP was associated with a reduced risk of pancreatic cancer (P for trend = 0.048); the adjusted odds ratio for the highest category of PLP (>52.4 nmol/L) was 0.46 (95% CI 0.23, 0.92) compared to vitamin B

conclusionsHigher concentrations of PLP may protect against the development of pancreatic cancer. The protective effect may be more apparent in populations with low concentrations of circulating vitamin B

Indexed as

AgedAsian PeopleBiomarkers, TumorCase-Control StudiesFemaleHumansMaleMiddle AgedPancreatic NeoplasmsProspective StudiesPyridoxalPyridoxal PhosphatePyridoxic AcidRisk FactorsSingaporeVitamin B 6Biomarkers, TumorPyridoxalPyridoxal PhosphatePyridoxic AcidVitamin B 6Vitamin B ComplexBiomarkerCase–control studiesCohort studiesEpidemiologyPancreatic cancerPyridoxal 5′-phosphateRisk factorsVitamin B6

Identifiers

PMID27830400
PMCPMC5161671
OpenAlexW2556330233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.